The 'Falsified Medicines Directive' webinar has been rescheduled to Tuesday 14th March 2017 @ 4pm. Anne Hayes (Inspection Manager, HPRA) and Professor Claude Farrugia (EIPG President & University of Malta) will present. Registration details will be available in early March 2017.
Unfortunately due to unforeseen circumstances we have had to postpone the webinar on the 'Falsified Medicines Directive' which was due to take place this Wednesday, 1st February, with Anne Hayes of the HPRA and Dr Claude Farrugia of the EIPG & University of Malta. We hope to be able to reschedule the webinar soon.
Latest edition of European Industrial Pharmacy journal now available EIPG31_Journal final lr which includes an interesting article on regenerative medicine.
A leading Pharmacy Homecare Company is currently recruiting for a clinical pharmacist. The ideal candidate will have 2 or more years post-qualification experience in either a Hospital or Community position. See further details, see http://localhost/pier2016/current-vacancies.
The presentation from the 'Adaptive Licensing for Medicinal Products' webinar is available in the members area on the PIER website.
The PSI is currently seeking expressions of interest from individuals who wish to participate in the work of the PSI through its Advisory and Disciplinary Committees. To express interest, apply online via online application form by Friday 25th of November 2016. For further information see:
A new HPRA Innovation Office has been set up to support the development of novel health products and technologies.  For further details see:
QuintilesIMS are organising a webinar entitled 'The Evolution of Regulatory Affairs' on Wednesday 7th December 2016 at 4pm GMT. The duration is 1 hour. Register via this link:
PIER members are welcome to attend the 'Biosimilars 360 Symposium' in Royal College of Physicians, Kildare Street, Dublin on Saturday 12th Nov 2016 (10am-4pm). See invitation biosimilars-symposium_invitation_12-nov-2016. The objectives of this symposium are to provide participants with an up-to-date review of the most recent and clinically relevant developments in research, authorisation, regulation, real world evidence/practice, pharmacoeconomics, clinical therapeutic management and the patient’s perspective of biosimilars. The agenda includes both national and international speakers, most notably from the HPRA, the Norwegian Medicines Agency, NOR-SWITCH overview of results, the patient’s perspective - IPPOSI, a Health & Value perspective, and a case study on a switch study in Southampton University Trust Hospitals. Further details about the symposium (agenda, speakers etc.) are available through the website is free. If you have any questions, feel free to contact PIER Member Ed McGettrick who involved in organising this event on or 01 4676500.

Get in touch

C/o School of Pharmacy,
Cavanagh Building,
University College Cork.

Get in touch

Privacy policy

We're Social

Mailing List Signup

Email address: